GIGYF1, which is associated with Autism Spectrum Disorder (ASD) and indirectly linked to AD, as well as ADAMTSL4, involved in the metabolism of amyloidogenic peptides in AD, were both down-regulated in ACD patients. This evidence concerns the gene GIGYF1 and granular corneal dystrophy type II.